300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Theatre
Food and Beverage
Medical
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Recruiting
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Web3
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Canada
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
United Kingdom
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Huang Li, Founding Partner & CEO at Cowin Capital

Huang Li

Founding Partner & CEO @ Cowin Capital

Huang Li is a Series A investor at Cowin Capital focused on Biotechnology and Medical Device. Money and Banking Nankai University master's and doctoral finance, global CEO Yangtze classes.Cowin founding partner, Nanhai Growth Fund founding partner. Tianjin Private Equity Association sponsors director.Has 10 years of investment banking qualifications, as the first batch of investment bankers, to witness the growth of China'scapital market, a large number of enterprises to provide financial, restructuring and listing, and financing services.With 20 years of professional experience in securities, investment in the investment banking industry has a profound understanding of the industry has a good relationship with them.

Total investments:
4
Last investment:
Lead investor:
25%

Last updated:

Industries Huang Li invests in

BiotechnologyMedical DevicePharmaceuticalBiopharmaLife Science

Stages Huang Li invests in

Series ASeedSeries B

Countries Huang Li invests in

China

Investment Focus

Industry

  • Biotechnology 2 (50%)
  • Medical Device 2 (50%)
  • Pharmaceutical 2 (50%)
  • Biopharma 1 (25%)
  • Life Science 1 (25%)
See all 6 industries →

Stage

  • Series A 2 (50%)
  • Seed 1 (25%)
  • Series B 1 (25%)

Investments

CompanyDescriptionRoundLinks
AnDiConBio AnDiConBio
developer of respiratory anti-infection drugs, offering high-potential, low-risk products like new anti-influenza and oral anti-new coronavirus. $27.6M / Series A / Apr 29, 2024
Cosminde Cosminde
Cosminde is a developer of gastroenterology soft electronic endoscope products. Series A / Dec 12, 2023
Cosminde Cosminde
Cosminde is a developer of gastroenterology soft electronic endoscope products. Seed / Jan 16, 2023
Wellgrow Technology Wellgrow Technology
Wellgrow Technology is a developer of in vitro diagnostic medical equipment and reagents for life sciences, clinical medical diagnostics, and food safety. Series B / Jan 25, 2022

Co-Investors

The National Innovation Center The National Innovation Center 2 deals together BlackRock BlackRock 1 deal together
China Merchants Health China Merchants Health 1 deal together
Huajin Avenue Investment Huajin Avenue Investment 1 deal together
Huajin Capital Huajin Capital 1 deal together
IDG Capital IDG Capital 1 deal together
Cowin Capital

About Cowin Capital

VC Fund · Shenzhen, China

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Cowin Capital Contacts

NameEmailPhoneSocials
Cai Weiliang
Cai Weiliang Partner
Ding Baoyu
Ding Baoyu Managing Director, Partner
Dong Dongdong
Dong Dongdong Partner
Dong Ming
Dong Ming Hangzhou Area Partner
Huang Li
Huang Li Founding Partner & CEO

Sign up to unlock verified contacts

Unlock Contacts
Open Cowin Capital full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Theatre
Food and Beverage
Medical
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Recruiting
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Web3
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Oman
Africa
Oceania
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Canada
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
United Kingdom
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Huang Li invest in?

Huang Li invests primarily in Biotechnology, Medical Device and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Huang Li last invest?

The most recent investment recorded for Huang Li closed in Apr 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Huang Li Huang Li Find email